Reducing Blood Culture Contamination
A novel device promises better blood cultures and more-appropriate antibiotic use at reduced cost.
Read More
Search Results for: liver disease
Ortho Gets FDA Nod for Insulin Reagent, Calibrators
An important biomarker in diabetes and prediabetes testing, the assay is expected to be commercially available for use on all of Ortho’s Vitros immunodiagnostic and integrated systems in the United States during the third quarter of this year.
Read More
Inside Track: Precision Partnering
A novel partnership takes aim at developing NGS companion diagnostics in oncology.
Read More
ProSciento, Owl Metabolomics Seek to Accelerate Clinical Trial Recruitment
The companies have entered into an exclusive, multiyear partnership to employ noninvasive, lipidomics-based diagnostic testing to establish a database enriched for subjects with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Read More
Quest Diagnostics to Form Precision Oncology Center
Quest is acquiring two diagnostic laboratories in Texas, with the aim of establishing a center of excellence that will provide diagnostic services to aid in the detection and management of cancer for oncologists and patients nationwide.
Read More